Evidence map›Paper›PMID 15322052›Full record

ArticleInfection and immunity2004

Development of a novel chloramphenicol resistance expression plasmid used for genetic complementation of a fliG deletion mutant in Treponema denticola.

Linda L Slivienski-Gebhardt, Jacques Izard, William A Samsonoff, Ronald J Limberger

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Genetic Manipulations of Oral Spirochete Treponema denticola.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  5. The Role ofFrontiers in cellular and infection microbiology · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Treponema denticola interactions with host proteins.Journal of oral microbiology · 2012
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Linda L Slivienski-GebhardtDavid Axelrod Institute for Public Health, Wadsworth Center, New York State, Department of Health, P.O. Box 22002, Albany, NY 12201-2002, USA.
Jacques Izard
William A Samsonoff
Ronald J Limberger
Wadsworth Center · USNew York State Department of Health · US

Funding

MOLECULAR ANALYSIS OF TREPONEMAL MOTILITY GENESR01AI034354 · NIAID · WADSWORTH CENTER · PI LIMBERGER, RONALD J · 1999 to 2002
$618k
MOLECULAR ANALYSIS OF TREPONEMAL MOTILITY GENESR29AI034354 · NIAID · WADSWORTH CENTER · PI LIMBERGER, RONALD J · 1993 to 1997
–
NIAID NIH HHS AI34354
6 · The paper itself

Abstract

A new expression plasmid containing the fla operon promoter and a staphylococcal chloramphenicol resistance gene, was constructed to help assess the role of fliG in Treponema denticola motility. Deletion of fliG resulted in a nonmotile mutant with a markedly decreased number of flagellar filaments. Wild-type fliG genes from T. denticola and from Treponema pallidum were cloned into this expression plasmid. In both cases, the gene restored the ability of the mutant to gyrate its cell ends and enabled colony spreading in agarose. This shuttle plasmid enables high-level expression of genes in T. denticola and possesses an efficient selectable marker that provides a new tool for treponemal genetics.

Indexed as

Drug Resistance, BacterialGenetic Complementation TestPlasmidsAnti-Bacterial AgentsBacterial ProteinsChloramphenicolGene DeletionHumansMolecular Sequence DataSequence Analysis, DNATreponemaAnti-Bacterial AgentsBacterial ProteinsChloramphenicolFlig protein, Bacteria

Identifiers

PMID15322052
PMCPMC517452
OpenAlexW2080402521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.